小儿肺炎采用阿奇霉素与痰热清联合治疗的临床应用分析

来源 :大家健康(学术版) | 被引量 : 0次 | 上传用户:wangmeiqing
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探究分析阿奇霉素和痰热清联合治疗小儿肺炎的临床疗效。方法:采用回顾性分析的方法,分析了我院在2013年6月1日至2014年3月1日间收治的108例患有肺炎的小儿患者的临床资料,根据治疗方法的不同,随机分成对照组和实验组,每组各54例,给予两组患者相同的对症处理,对照组给予阿奇霉素予以序贯治疗,实验组在其基础之上,予以痰热清的注射治疗,观察比较两组患者体征消失的时间及治疗情况。结果:实验组患者症状消失的时间为(3.2±1.5)天,远远少于对照组的(6.1±2.1)天,实验组的治疗有效率达98.15%,远远高于对照组的66.67%,且两组数据差异符合统计学的意义,其P<0.05。结论:阿奇霉素和痰热清联合应用治疗小儿肺炎,可大大提高其治疗有效率,缩短治疗时间,减轻患儿痛苦,值得临床广泛推广使用。 Objective: To investigate the clinical efficacy of azithromycin combined with Tanreqing in the treatment of pneumonia in children. Methods: The retrospective analysis was used to analyze the clinical data of 108 pediatric patients with pneumonia admitted to our hospital from June 1, 2013 to March 1, 2014. According to the different treatment methods, the patients were randomly divided into The control group and the experimental group, each group of 54 cases, given the same symptomatic treatment of two groups of patients, the control group given azithromycin to be treated sequentially, the experimental group on the basis of it, to be Tanreqing injection treatment, observation and comparison of two groups Patient signs and disappearance of the time and treatment. Results: The symptoms disappeared in the experimental group (3.2 ± 1.5 days), far less than the control group (6.1 ± 2.1) days. The effective rate of the experimental group reached 98.15%, which was much higher than that of the control group (66.67% , And the difference between the two groups of data was statistically significant (P <0.05). Conclusion: Azithromycin and Tanreqing combined application of treatment of children with pneumonia can greatly improve the treatment efficiency, shorten the treatment time, reduce the pain of children, it is widely used in clinical.
其他文献
目的:对吸入性布地奈德治疗毛细支气管炎效果进行临床探讨,以求寻找并完善治疗效果较好的治疗方式。方法:选取2013年2月~2014年2月期间在我院接受治疗的毛细支气管炎患者50例,随机
目的:研究分析糖尿病高血压患者的药物治疗措施。方法:以55例糖尿病高血压患者为入组对象,采用简单抽样方式将55例患者随机分为两组,对照组25例,临床期间采用苯磺左旋氨氯地平口服
目的:探讨疏血通注射液与静脉用药联合对急性脑梗死进行治疗的安全性与合理性。方法:选择我院2010年8月至2013年9月收治的72例急性脑梗死患者为研究对象,随机分为对照组36例,观察
目的:随着药理学的发展,发现许多药物在体内的吸收、分布、代谢和排泄等有明显的时间节律性。同一种药物、同一剂量,不同的服药时间,其疗效和毒性可相差几倍,甚至几十倍。因此患者